Validation of the 4-Week Recall Version of the Uterine Fibroid Symptom and Health-Related Quality of Life (UFS-QOL) Questionnaire.

CONCLUSIONS: The 4-week recall version of the UFS-QoL demonstrated good internal consistency reliability, concurrent validity, and responsiveness and is psychometrically comparable to the original 3-month recall UFS-QoL. CLINICAL TRIAL REGISTRATION: Data from a Phase 2a, Cohort Design Proof of Concept Study (Trial M12-663); ClinicalTrials.gov Identifier NCT01441635. Date of Registration: September 6, 2011. PMID: 27733082 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/27733082?dopt=Abstract

Source: Current Medical Research and Opinion - October 14, 2016 Category: Research Tags: Curr Med Res Opin Source Type: research

More News: Research